arginine has been researched along with podophyllotoxin in 263 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 224 (85.17) | 18.7374 |
| 1990's | 28 (10.65) | 18.2507 |
| 2000's | 7 (2.66) | 29.6817 |
| 2010's | 4 (1.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Grieder, A; Maurer, R; Stähelin, H | 1 |
| Gangji, D; Hildebrand, J; Machin, D; Nouwynck, C | 1 |
| Basugi, N; Nomura, K; Sano, K; Shitara, N; Takakura, K; Yamamoto, H | 1 |
| El-Morsi, B; El-Sebai, IT; Gad-el-Mawla, NM; Hamza, MR; Khafagy, M; Mansour, MA; Muggia, FM; Sherif, M | 1 |
| Poschmann, G; Stähelin, H | 1 |
| De Pauw, M; Denis, L; Lachand, A; Pavone-Macaluso, M; Robinson, M; Schulman, C; Smith, P; Staquet, M; Sylvester, R | 1 |
| García-Cañero, R; Gosalvez, M; Reinhold, H | 1 |
| Buge, A; Huguenin, P; M'orin, P; Mathé, G; Palangie, T; Parrot, R; Poisson, M; Pouillart, P | 1 |
| Baker, LH; Fraile, RJ; Samson, MK; Talley, RW | 1 |
| Bunn, PA; Ihde, DC; Radice, PA | 1 |
| Hassoun, J; Paillas, JE; Pellet, W; Peragut, JC; Prince, MA | 1 |
| Sano, K; Shitara, N; Takakura, K; Yamamoto, H | 1 |
| Henney, JE; Muggia, FM; Rozencweig, M; Von Hoff, DD | 1 |
| Charron, D; Dumonchel, P; Jorry, F; Laurens, A; Martola, R; Thevenot, J | 1 |
| Jankowski, RP; Vahrson, H | 1 |
| Gautier, H; Huguenin, P; Lheritier, J; Mathé, G; Morin, P; Palangie, T; Parrot, R; Poisson, M; Pouillart, P | 1 |
| Bellet, RE; Berd, D; Catalno, RB; Koons, LS; Mastrangelo, MJ | 1 |
| Buge, A; Poisson, M; Pouillart, P | 1 |
| Herson, J; Ragab, A; Sexhauer, C; Starling, KA; Sullivan, MP; van Eys, J | 1 |
| Begg, CB; Bennett, JM; Brodovsky, HS; Carbone, PP; Chiuten, DF; Creech, RH; Falkson, G; Glick, J; Muggia, FM | 1 |
| Bleyer, WA; Chard, RL; Hammond, D; Krivit, W | 1 |
| Crooke, ST; Gutierrez, ML | 1 |
| Baker, LH; Fraile, RJ; Hire, EA; Samson, MK | 1 |
| Foley, JF; Kessinger, A; Lemon, HM | 1 |
| Markwalder, H; Seiler, RW; Vassella, F | 1 |
| Bataini, JP; Mashaly, R; Metzger, J; Pertuiset, BF; Poisson, M; Pouillart, P | 1 |
| Bataini, JP; Hauw, JJ; Mashaly, R; Metzger, J; Pertuiset, BF; Poisson, M; Pouillart, P | 1 |
| Cappelli-Gotzos, B; Despond, JM; Gotzos, V | 1 |
| Garcia-Giralt, E; Jouve, M; Magdelenat, H; Palangie, T; Pouillart, P | 1 |
| Osswald, H | 1 |
| Avery, T; Green, A; Hayes, A; Pratt, C; Rivera, G | 1 |
| Gutin, PH; Walker, MD | 1 |
| Allen, LM | 1 |
| Baron, A; Blic, V; Garcia-Giralt, E; Gautier, H; Huguenin, P; Jouve, M; Langlois, A; Morin, P; Palangie, T; Pouillart, P; Regensberg, C | 1 |
| Brewer, CF; Gensler, WJ; Horwitz, SB; Loike, JD; Sternlicht, H | 1 |
| Coulter, D; Kalish, R; Valeriote, FA; Vietti, TJ | 1 |
| de Tribolet, N; Wagenknecht, L; Zander, E | 1 |
| Allen, L | 1 |
| Aimard, G; Chassard, JL; Devic, M; Tommasi, M; Trouillas, P | 1 |
| Albahary, C; Amiel, JL; Belpomme, D; de Vassal, F; Depierre, R; Hayat, M; Jasmin, C; Mathé, G; Misset, JL; Musset, M; Pouillart, P; Schwarzenberg, L | 1 |
| D'Estienne d'Orves, JF; Paillas, JE; Pellet, W; Pollet, JF | 1 |
| Buge, A; Gautier, H; Huguenin, P; Lheritier, J; Mathé, G; Morin, P; Parrot, R; Poisson, M; Pouillart, P; Thy, HT | 1 |
| Caramia, G; Messana, V; Pavone-Macaluso, M; Rizzo, FP | 1 |
| Kenis, Y; Rozencweig, M; Schulman, CC; Staquet, M; Sylvester, R | 1 |
| Hacker, M; Roberts, D | 1 |
| Mechl, Z; Rovný, F; Sopková, B | 1 |
| Barouh, M; Carpentier, Y; Cattan, A; Cattan, E; Pourny, C | 1 |
| Stähelin, H | 1 |
| Gauthier, H; Huguenin, P; Lheritier, J; Mathe, G; Morin, P; Parrot, R; Poisson, M; Pouillart, P; Thy, TH | 1 |
| Donaldson, MH; Rosenstock, JG | 1 |
| Bodrogi, I; Döbrentey, E; Eckhardt, S | 1 |
| Allen, LM; Creaven, PJ | 1 |
| Avery, T; Rivera, G; Roberts, DW | 1 |
| Amiel, JL; Mathé, G; Misset, JL; Oldham, R; Pouillart, P; Schwarzenberg, L; Weiner, R | 1 |
| Derry, WB; Gupta, RS; Pamidi, CC | 1 |
| Behm, FG; Evans, WE; Hancock, ML; Head, DR; Mahmoud, MH; Pui, CH; Raimondi, SC; Ribeiro, RC; Rivera, GK; Sandlund, JT | 1 |
| Stähelin, HF; von Wartburg, A | 1 |
| Bugat, R; Canal, P; Chatelut, E; Chevreau, C; de Forni, M; Houin, G; Johnson, NP; Plusquellec, Y; Roche, H | 1 |
| Gupta, R | 1 |
| Schaack, J; Schedl, P; Shenk, T | 1 |
| Schaak, J; Schedl, P; Shenk, T | 1 |
| Dunaway, M | 1 |
| Preston, GM; White, BA | 1 |
| Beck, WT; Danks, MK; Fernandes, DJ | 1 |
| Kiue, A; Kohno, K; Kuwano, M; Matsuo, K; Sato, S; Takano, H | 1 |
| Björkholm, M | 1 |
| Einstein, AB; Fleming, TR; Laufman, L; Macdonald, JS; Natale, RB; Oishi, N; Ungerleider, JS; Von Hoff, DD | 1 |
| Evans, WE; Kavanagh, RL; Ochs, J; Rivera, GK; Rodman, JH; Sunderland, M; Yalowich, J | 1 |
| D'Incalci, M; Figoli, F; Montaldo, PG; Sorio, R; Tirelli, U; Zanette, ML; Zucchetti, M | 1 |
| Huang, L; White, JC; Wright, SE | 1 |
| Carbone, A; Monfardini, S; Sorio, R; Tirelli, U; Zagonel, V | 1 |
| Boas, J; Dombernowsky, P; Engelholm, SA; Hansen, OP; Rasmussen, D | 1 |
| Bundy, BN; Given, FT; Muss, HB; Stehman, FB | 1 |
| Bertelsen, K; Cold, S; Panduro, J; Pfeiffer, P; Rose, C; Sandberg, E | 1 |
| Hines, LH; White, JC; Wright, SE | 1 |
| Bogdahn, U; Dünisch, G; Löbering, HG; Martin, R; Mertens, HG; Weber, H; Zapf, J | 1 |
| Carstensen, H; Hertz, H; Nolte, H | 2 |
| Beerman, TA; Sigmund, RD; Woynarowski, JM | 2 |
| Chen, AY; Hwang, JL; Juan, CC; Shyy, SH; Whang-Peng, J | 1 |
| Foglesong, PD; Parganas, E; Roberts, DW; Wiggins, L | 1 |
| Beck, WT; Danks, MK; Schmidt, CA; Wolverton, JS | 1 |
| Hsiang, YH; Liu, LF | 1 |
| Cellerino, R; Di Furia, L; Gramazio, A; Guidi, F; Menichetti, E; Tummarello, D | 1 |
| Beerman, TA; Cullinan, EB | 1 |
| Lönn, S; Lönn, U; Nylen, U; Winblad, G | 1 |
| Beck, WT; Danks, MK; Deneka, DA; Schmidt, CA | 1 |
| Ellis, AL; Gewirtz, DA; Povirk, LF; Randolph, JK; Swerdlow, PS; Yalowich, JC; Yanovich, S | 1 |
| Martin, J; Nunn, AJ; Siddall, SJ | 1 |
| Kinouchi, T; Kotake, T; Kuroda, M; Maeda, O; Miki, T; Saiki, S; Tomooka, Y; Usami, M; Yoshimura, K | 1 |
| Bult, A; Holthuis, JJ; van Bennekom, WP; van der Horst, FA; van Opstal, MA | 1 |
| Bugat, R; Canal, P; Chatelut, E; Chevreau, C; De Forni, M; Houin, G | 1 |
| Bugat, R; Canal, P; Carton, M; Chatelut, E; Houin, G; Pinel, MC; Plusquellec, Y | 1 |
| Bugat, R; Canal, P; Chatelut, E; De Biasi, J; Houin, G; Plusquellec, Y | 1 |
| White, JC; Wright, SE | 3 |
| McVie, G; Muggia, FM | 1 |
| Bodley, AL; Kupfer, G; Liu, LF | 1 |
| Boyce, RA; Hertzberg, RP; Mattern, MR; Schein, PS; Tan, KB | 1 |
| D'Incalci, M; Figoli, F; Lestuzzi, C; Monfardini, S; Sorio, R; Tirelli, U; Urso, R; Zanette, ML | 1 |
| Bonardi, GM; Calciati, A; Donadio, M; Giaccone, G; Testore, F | 1 |
| Bonardi, G; Calciati, A; Donadio, M; Giaccone, G; Testore, F | 1 |
| Chow, KC; Macdonald, TL; Ross, WE | 1 |
| Richter, A; Strausfeld, U | 1 |
| Brunner, KW; Cerny, T; Joss, RA; Pedrazzini, A | 1 |
| Berendsen, HH; Haaxma-Reiche, H; Postmus, PE | 1 |
| Jacobson-Kram, D; Lim, M; Liu, LF; Williams, JR | 1 |
| Elinder, G; Finkel, Y; Henter, JI; Söder, O | 1 |
| Beck, WT; Cirtain, MC; Danks, MK; Felsted, RL; Safa, AR; Suttle, DP; Trent, JM; Wolverton, JS | 1 |
| Liu, LF; Rowe, TC; Yang, L | 1 |
| Haim, N; Nemec, J; Roman, J; Sinha, BK | 1 |
| Bork, E; Dombernowsky, P; Hansen, HH; Hansen, M; Hansen, SW; Pedersen, AG | 1 |
| Brattain, MG; Long, BH; Musial, ST | 3 |
| Eguchi, K; Morinaga, S; Saijo, N; Sakurai, M; Sano, T; Sasaki, Y; Shinkai, T; Suga, J; Tamura, T | 1 |
| Bagatella, M; Bonardi, G; Calciati, A; Ciuffreda, L; Donadio, M; Ferrati, P; Giaccone, G | 1 |
| Knippers, R; Richter, A; Strausfeld, U | 1 |
| Bezwoda, WR; Derman, DP; Kew, M; Weaving, A | 1 |
| Kerrigan, D; Kohn, KW; Pommier, Y | 1 |
| Holthuis, JJ | 1 |
| Dombernowsky, P; Hansen, HH | 1 |
| D'Incalci, M; Garattini, S | 2 |
| Bugat, R; Canal, P; Douste-Blazy, L; Hamza, M; Soula, G | 1 |
| Bakkenist, TR; de Vries, J; Lankelma, J; Pinedo, HM; Retèl, J; van den Akker, E; Van Maanen, JM | 1 |
| Bezanilla Regato, JL; Moya Calderón, E; Navajas Gutiérrez, A; Piñán, MA | 1 |
| Rivera, GK | 1 |
| Grem, JL; Hoth, DF; King, SA; Leyland-Jones, B; Ungerleider, RS; Wittes, RE | 1 |
| Clark, PI; Slevin, ML | 1 |
| Bromke, A; Bryant, DW; Gupta, R; Gupta, RS; McCalla, DR; Singh, B | 1 |
| Carpenter, JT; Cox, EB; Raney, M; Vogel, CL | 1 |
| Aso, Y; Fukushima, M; Matsuura, O; Naide, Y; Ohshima, S; Ono, Y; Ota, K; Suzuki, K; Tajima, A; Ushiyama, T | 1 |
| Chenchaiah, PC; Gupta, R; Gupta, RS | 1 |
| Chenchaiah, PC; Gupta, RS | 1 |
| Beck, WT; Danks, MK; Yalowich, JC | 1 |
| Forman, SJ; Levitt, LJ; Linker, CA; O'Donnell, M; Ries, CA | 1 |
| Büchner, T; Ganser, A; Heil, G; Heimpel, H; Hoelzer, D; Koch, P; Kurrle, E; Lipp, T; Löffler, H; Thiel, E | 1 |
| Culbert, SJ; Frankel, LS; Shimizu, H | 1 |
| Fortner, CL; King, SA; Leyland-Jones, B; O'Dwyer, PJ | 1 |
| Bundy, BN; DiSaia, PJ; Muss, H; Twiggs, LB | 1 |
| Blume, KG; Forman, SJ; Krance, RA | 1 |
| Elinder, G; Finkel, Y; Henter, JI; Holmström, S; Karlén, J; Sahlgren, B; Söder, O | 1 |
| Ashmun, R; Lee, T; Parganas, E; Roberts, D; Wiggins, L; Yalowich, J | 1 |
| de Vries, LG; Holthuis, JJ; Hulshoff, A; Mulder, NH; Postmus, PE; Sleijfer, DT; van Oort, WW; Verleun, H | 1 |
| Abromowitch, M; Evans, WE; Hayes, FA; Rivera, GK; Rodman, JH; Sinkule, JA | 1 |
| Candiloro, V; Flandina, C; Gagliano, M; Gebbia, N; Leto, G; Rausa, L; Sanguedolce, R; Tumminello, FM | 1 |
| Bundy, BN; Muss, HB; Yazigi, R; Yordan, E | 1 |
| Carstensen, H; Hertz, H; Jensen, T; Nolte, H | 1 |
| Carbone, A; Galligioni, E; Grigoletto, E; Roncadin, M; Tirelli, U; Tumolo, S; Veronesi, A; Zagonel, V | 1 |
| Canetta, R; Carbone, A; Tirelli, U; Veronesi, A; Zagonel, V | 1 |
| Kooiman, A; Neijt, JP; ten Bokkel Huinink, WW; van der Burg, ME; van Oosterom, AT; van Putten, WL; Vermorken, JB; Vriesendorp, R | 1 |
| Berenberg, J; Blumenstein, BA; Bukowski, RM; Johnson, K; O'Bryan, RM; Oishi, N; Quagliana, J; Rivkin, SE; Saiers, JH; Stephens, RL | 1 |
| Amato, G; Broggini, M; Colombo, T; D'Incalci, M; Erba, E; Vaghi, M | 1 |
| Bugat, R; Canal, P; Carton, M; Michel, C; Soula, G | 1 |
| de Vries, EG; Mulder, NH; Postmus, PE; Sleijfer, DT; Vriesendorp, R; Willemse, PH | 1 |
| Hiraoka, M; Nakanomyo, H; Shiraya, M | 1 |
| Berg, D; Bugat, R; Canal, P; Roche, H; Rokoszak, B; Soula, G | 1 |
| Christensen, IJ; Hansen, HH; Roed, H; Spang-Thomsen, M; Vindelov, LL | 1 |
| Brock, KH; DeMarini, DM; Doerr, CL; Moore, MM | 1 |
| Abromowitch, M; Dahl, GV; Kalwinsky, DK; Look, AT; Mirro, J; Murphy, SB; Ochs, J; Pui, CH; Rivera, G | 1 |
| Abromowitch, M; Green, AA; Hayes, FA | 1 |
| Brema, F; Carbone, A; Grigoletto, E; Tirelli, U; Veronesi, A; Volpe, R; Zagonei, V | 1 |
| Bitran, J; Gordon, L; Johnson, C; Khandekar, JD; Krauss, S; Lanzotti, V; Locker, GY; Shaw, J; Sweet, D | 1 |
| D'Incalci, M; Farina, P; Mangioni, C; Rossi, C; Sessa, C; Urso, R; Zucchetti, M | 1 |
| Hines, LH; Rathmell, JP; White, JC | 1 |
| Bugat, R; Canal, P; Combes, PF; Michel, C; Roche, H; Soula, G | 1 |
| Hill, BT; Pritchard, J; Whelan, R | 1 |
| Gewirtz, DA | 1 |
| Bodey, GP; Brown, NS; Ho, DH; Issell, BF; Kanellopoulos, KS | 1 |
| Kinouchi, T; Kiyohara, H; Kotake, T; Kuroda, M; Miki, T; Oda, H; Saiki, S; Usami, M | 1 |
| Chen, GL; Halligan, BD; Liu, LF; Rowe, TC; Tewey, KM; Yang, L | 1 |
| Glisson, B; Liu, L; Ross, W; Rowe, T; Yalowich, J | 1 |
| Bork, E; Dombernowsky, P; Hansen, HH; Osterlind, K; Pedersen, AG | 1 |
| Baumelou, A; Habibi, B; Seradaru, M | 1 |
| Rysánková, J; Uchytil, B | 1 |
| Funnell, CF; Hope, DM; Humphrey, DC; Lowenthal, RM; Stewart, IG | 1 |
| Fry, DW; Goldman, ID; Yalowich, JC | 1 |
| Crom, WR; Evans, WE; Hutson, PR; Sinkule, JA; Stewart, CF; Yee, GC | 1 |
| Markwalder, H; Seiler, RW; Zimmermann, A | 1 |
| Di Stefano, E; Gerosa, MA; Olivi, A | 1 |
| Calciati, A; Conte, PF; Giaccone, G; Musella, R | 1 |
| Barrere, M; Bes, A; Fanjaud, G; Geraud, G; Larrue, V | 1 |
| Long, BH; Minocha, A | 1 |
| Płuzańska, A; Robak, T | 1 |
| Campbell, AM; Ekert, H; Waters, KD | 1 |
| Carbone, A; Crivellari, D; Franchin, G; Galligioni, E; Grigoletto, E; Tirelli, U; Trovò, M; Tumolo, S; Veronesi, A; Volpe, R | 1 |
| Alonso, MT; Leyland-Jones, B; Marsoni, S; O'Dwyer, PJ | 1 |
| Gasalla Chacón, R; Gónzalez Larriba, JL; Grande, C; Montero García, JM; Picaporte, MA | 1 |
| D'Incalci, M; Mangioni, C; Rossi, C; Sessa, C; Urso, R; Zucchetti, M | 1 |
| Crivellari, D; Franchin, G; Galligioni, E; Grigoletto, E; Talamini, R; Tirelli, U; Trovó, MG; Tumolo, S; Veronesi, A | 1 |
| Dennery, J; Hopkins, HS; Hugenholtz, H; Montpetit, V; Nundy, D; Prior, J; Richard, MT; Stewart, DJ | 1 |
| Bellamy, AS; Hill, BT | 1 |
| Dow, LW; Evans, WE; Horvath, A; Look, AT; Sinkule, JA | 1 |
| Crom, WR; Dahl, GV; Evans, WE; Melton, ET; Sinkule, JA; Stewart, CF | 1 |
| Gupta, RS; Singh, B | 1 |
| Carreras, E; Grañena, A; Marín, P; Olivé, MT; Rozman, C; Sierra, J | 1 |
| Rafecas, FJ; Sanz, MA | 1 |
| Brinkman, UA; de Ruiter, C; de Vries, J; Frei, RW; Werkhoven-Goewie, CE | 1 |
| Alberts, DS; Dorr, RT | 1 |
| Evans, WE; Sinkule, JA | 1 |
| Lee, T; Roberts, D | 2 |
| Colombo, N; D'Incalci, M; Landoni, F; Mangioni, C; Sessa, C | 1 |
| Canetta, R; D'Incalci, M; Franchin, G; Galligioni, E; Grigoletto, E; Rossi, C; Tirelli, U; Trovò, MG; Tumolo, S; Veronesi, A | 1 |
| Dalesio, O; de Pauw, M; Denis, L; Robinson, M; Schulman, CC; Smith, P; Sylvester, R; Viggiano, G | 1 |
| Anderson, J; Bennett, JM; Berard, CW; Brodovsky, HS; Glick, JH; Merrill, JM; Neiman, RS; O'Connell, MJ | 1 |
| Fuerst, ML | 1 |
| Gupta, RS | 1 |
| Broggini, M; Colombo, T; D'Incalci, M | 1 |
| Aur, RJ; Avery, TL; Bowman, WP; Dahl, GV; Rivera, G; Wood, A | 1 |
| Carbone, A; Franchin, G; Galligioni, E; Grigoletto, E; Tirelli, U; Trovo, MG; Tumolo, S; Veronesi, A; Volpe, R | 1 |
| Razon-Veronesi, S | 1 |
| De Bruyne, GK; Dragonetti, CH; Mareel, MM; Van Cauwenberge, RM | 1 |
| Aur, RJ; Avery, TL; Bowman, WP; Dahl, GV; Kalwinsky, DK; Murphy, SB; Rivera, G; Stagner, S; Wood, A | 1 |
| Dombernowsky, P; Hansen, HH; Nissen, NI; Pedersen, AG | 1 |
| Kondrat'eva, NA; Maiakova, SA; Makhonova, LA; Vialushkin, BIa | 1 |
| Gershanovich, ML; Kondrat'ev, VB; Kondrat'eva, NA; Lebedev, VN; Vialushkin, VIa | 1 |
| Straus, DJ; Warrell, RP; Young, CW | 1 |
| Loike, JD | 1 |
| Creaven, PJ | 1 |
| Issell, BF | 1 |
| Macbeth, FR | 1 |
| Bedogni, P; Canetta, R; Florentine, S; Hilgard, P; Lenaz, L | 1 |
| Elson, P; Khandekar, JD; Qazi, R | 1 |
| Baumelou, A; Habibi, B; Lopez, M; Marteau, R; Salmon, C; Serdaru, M; Vonlanthen, M | 1 |
| Curry, ME; Issell, BF; Tihon, C | 1 |
| Crom, WR; Dow, L; Evans, WE; Look, AT; Rivera, G; Sinkule, JA | 1 |
| Allen, LM; Nordqvist, S; Okonmah, AD; Tejada, F | 1 |
| Aur, RJ; Avery, TL; Bowman, WP; Dahl, GV; Murphy, SB; Rivera, G; Simone, JV | 1 |
| Casper, J; Cornet, J; Evans, WE; Green, AA; Hayes, FA | 1 |
| Abbou, C; Auvert, J; Botto, H; Garcia-Giralt, E; Hannoun, M; Jouve, M; Lachand, AT; Morin, P; Palangie, T; Pouillart, P | 1 |
| Colvin, M; Jardine, I; Strife, RJ | 2 |
| Gershanovich, ML; Kondrat'ev, VB; Kondrat'eva, NA; Lebedev, VN; Vygovskaia, IaI | 1 |
| Carbone, A; Galligioni, E; Grigoletto, E; Tirelli, U; Trovò, MG; Tumolo, S; Veronesi, A | 1 |
| Aur, RJ; Avery, TL; Dahl, GV; Pratt, CB; Rivera, G; Wood, A | 1 |
| Schulz, JJ; Speckhart, VJ; Spremulli, E; Wampler, GL | 1 |
| Seiler, RW | 1 |
| Hacker, M; Jackson, CW; Roberts, D | 1 |
| Hilliard, S; Peck, C; Roberts, D | 1 |
| Bastion, Y; Brice, P; Coiffier, B; Espinouse, D; Gisselbrecht, C; Haioun, C; Marolleau, JP; Reyes, F; Salles, G; Sonet, A | 1 |
| Chatterjee, R; Goldstone, AH; Katz, M; McGarrigle, HH; Mills, W | 1 |
| Gemba, K; Kiura, K; Matsumura, T; Moritaka, T; Ohnoshi, T; Segawa, Y; Shibayama, T; Tabata, M; Takigawa, N; Ueoka, H | 1 |
| Campling, BG; Jain, N; Lam, YM; Pym, J | 1 |
| Imbert, TF | 1 |
| Coffman, FD; Cohen, S; Fresa, KL; Hingley, ST; Mody, NS; Ye, X | 1 |
| Amylon, M; Barredo, JC; Borowitz, M; Camitta, BM; Kurtzberg, J; Laver, JH; Link, MP; Murphy, SB; Pullen, J; Ravindranath, Y; Schwenn, M; Shuster, J | 1 |
| Castro, MA; del Corral, JM; Feliciano, AS; Gordaliza, M | 1 |
| Bunn, PA; Simon, GR | 1 |
| Castro, MA; del Corral, JM; García, PA; Gómez-Zurita, MA; Gordaliza, M | 1 |
| Seiter, K | 1 |
| Lv, M; Tian, X; Xu, H | 1 |
| Lv, M; Xu, H | 1 |
| Hu, Y; Liao, JX; Liu, H; Sun, JS; Tu, YH | 1 |
| Jakobs, A; Klempnauer, KH; Yusenko, M | 1 |
25 review(s) available for arginine and podophyllotoxin
| Article | Year |
|---|---|
VM 26 and VP 16-213: a comparative analysis.
Topics: Animals; Brain Neoplasms; Drug Evaluation; Etoposide; Humans; Kinetics; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms, Experimental; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1977 |
Pediatric cancer chemotherapy: an updated review. I. Cis-Diammine--dichloroplatinum II (cisplatin), VM-26 (teniposide), VP-16 (etoposide), mitomycin C.
Topics: Child; Cisplatin; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Humans; Leukemia; Mitomycins; Neoplasms; Podophyllotoxin; Teniposide | 1979 |
The chemical and biological route from podophyllotoxin glucoside to etoposide: ninth Cain memorial Award lecture.
Topics: Aldehydes; Antineoplastic Agents; Cell Division; Cyclosporins; Etoposide; Glucosides; Growth Inhibitors; History, 19th Century; History, 20th Century; Plants, Medicinal; Plants, Toxic; Podophyllotoxin; Podophyllum; Structure-Activity Relationship; Teniposide | 1991 |
Etoposide and teniposide in the treatment of acute leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1990 |
A phase II study with teniposide (VM26) in patients with progressed or relapsed small cell lung cancer (SCLC).
Topics: Adult; Aged; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Retrospective Studies; Teniposide | 1989 |
Etoposide and teniposide. Bioanalysis, metabolism and clinical pharmacokinetics.
Topics: Etoposide; Humans; Podophyllotoxin; Teniposide | 1988 |
The epipodophyllotoxin derivatives VM26 and VP16: experimental and clinical aspects.
Topics: Animals; Antineoplastic Agents; Etoposide; Humans; Podophyllotoxin; Teniposide | 1988 |
Podophyllotoxin derivatives VP-16 and VM-26.
Topics: Animals; Drug Resistance; Etoposide; Humans; Molecular Structure; Podophyllotoxin; Teniposide | 1988 |
Podophyllotoxin derivatives VP-16 and VM-26.
Topics: Animals; Cell Survival; Drug Interactions; Drug Resistance; Etoposide; Humans; Podophyllotoxin; Teniposide | 1987 |
Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Humans; Leukemia, Lymphoid; Podophyllotoxin; Teniposide | 1988 |
The clinical pharmacology of etoposide and teniposide.
Topics: Chemical Phenomena; Chemistry; Drug Stability; Etoposide; Humans; Kidney; Kinetics; Liver; Podophyllotoxin; Teniposide | 1987 |
Pharmacokinetics of anticancer drugs in children.
Topics: Aminoacridines; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Child; Cyclophosphamide; Etoposide; Humans; Kinetics; Mercaptopurine; Methotrexate; Naphthacenes; Podophyllotoxin; Teniposide; Vinca Alkaloids | 1983 |
Teniposide: a review of 12 years of experience.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Cycle; Cell Line; Child; Clinical Trials as Topic; Colonic Neoplasms; DNA, Neoplasm; Drug Evaluation, Preclinical; Drug Resistance; Humans; Leukemia; Lymphoma; Mice; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Podophyllotoxin; Teniposide | 1984 |
The epipodophyllotoxin derivatives VM-26 and VP-16-213, 1976-1979, a review.
Topics: Animals; Antineoplastic Agents; Etoposide; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lung Neoplasms; Podophyllotoxin; Teniposide | 1980 |
VP16-213 and podophyllotoxin. A study on the relationship between chemical structure and biological activity.
Topics: Animals; Chemical Phenomena; Chemistry; DNA; Etoposide; HeLa Cells; Humans; Microtubules; Molecular Conformation; Nucleosides; Podophyllotoxin; Structure-Activity Relationship; Teniposide | 1982 |
The clinical pharmacology of VM26 and VP16-213. A brief overview.
Topics: Biotransformation; Blood-Brain Barrier; Etoposide; Humans; Intestinal Absorption; Kinetics; Models, Biological; Podophyllotoxin; Teniposide; Tissue Distribution | 1982 |
The podophyllotoxin derivatives VP16-213 and VM26.
Topics: Animals; Chemical Phenomena; Chemistry; Drug Therapy, Combination; Etoposide; Humans; Neoplasms; Podophyllotoxin; Teniposide | 1982 |
VM26: phase I and II studies.
Topics: Drug Evaluation; Humans; Neoplasms; Podophyllotoxin; Teniposide | 1982 |
Current development of podophyllotoxins.
Topics: Chemistry, Pharmaceutical; Drug Compounding; Drug Stability; Drug Synergism; Drug Therapy, Combination; Etoposide; Humans; Kinetics; Podophyllotoxin; Teniposide | 1982 |
Antitumor properties of podophyllotoxin and related compounds.
Topics: Antineoplastic Agents, Phytogenic; Antiviral Agents; Etoposide; Humans; Immunosuppressive Agents; Podophyllotoxin; Structure-Activity Relationship; Teniposide | 2000 |
Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Microtubules; Multicenter Studies as Topic; Neoadjuvant Therapy; Organoplatinum Compounds; Paclitaxel; Palliative Care; Podophyllotoxin; Randomized Controlled Trials as Topic; Salvage Therapy; Survival Analysis; Taxoids; Teniposide; Treatment Outcome; Vinblastine; Vinorelbine | 2003 |
Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives.
Topics: Cytotoxins; Etoposide; Lignans; Organophosphorus Compounds; Plants, Toxic; Podophyllotoxin; Teniposide; Tumor Cells, Cultured | 2004 |
Toxicity of the topoisomerase II inhibitors.
Topics: Antineoplastic Agents; Cardiovascular Diseases; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Epirubicin; Etoposide; Humans; Idarubicin; Leukemia; Middle Aged; Mitoxantrone; Mucositis; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors; Vascular Diseases | 2005 |
A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Etoposide; Humans; Inhibitory Concentration 50; Organophosphorus Compounds; Podophyllotoxin; Structure-Activity Relationship; Teniposide | 2009 |
Recent advances in semisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: an update (2008-2010).
Topics: Antineoplastic Agents, Phytogenic; Cell Survival; Drug Screening Assays, Antitumor; Etoposide; Humans; Organophosphorus Compounds; Podophyllotoxin; Structure-Activity Relationship; Teniposide | 2011 |
39 trial(s) available for arginine and podophyllotoxin
| Article | Year |
|---|---|
Enhancement of bone marrow toxicity of VM-26-CCNU combination by bleomycin.
Topics: Adult; Aged; Bleomycin; Bone Marrow; Brain Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leukopenia; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1977 |
Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26.
Topics: Adolescent; Adult; Aged; Altretamine; Carcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Middle Aged; Podophyllotoxin; Schistosomiasis; Teniposide; Triazines; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 1978 |
Adjuvant therapy of T1 bladder carcinoma: preliminary results of an EORTC randomized study.
Topics: Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Pathology; Podophyllotoxin; Random Allocation; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1978 |
Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
Topics: Alopecia; Carcinoma, Small Cell; Clinical Trials as Topic; Drug Evaluation; Etoposide; Humans; Leukemia; Leukopenia; Lung Neoplasms; Lymphoma; Podophyllotoxin; Teniposide | 1979 |
[The toxicity of massive dosis of VM26 (4-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside). A contribution to the therapy of advanced ovarian cancer (author's transl)].
Topics: Aged; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nausea; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Teniposide; Vomiting | 1977 |
Treatment of malignant gliomas and brain metastases in adults using a combination of adriamycine, VM 26, and CCNU. Results of a type II trial.
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Glioma; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1977 |
Phase II trial of VM-26 in patients with metastatic malignant melanoma.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Teniposide | 1978 |
[A study of the use of sequential chemotherapy in 176 cases of glioblastoma (author's transl)].
Topics: Adult; Brain Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Follow-Up Studies; Glioma; Humans; Lomustine; Nitrosourea Compounds; Podophyllotoxin; Procarbazine; Random Allocation; Remission, Spontaneous; Teniposide; Time Factors | 1978 |
Nonresponsiveness of brain tumors to VM-26 therapy in children.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Humans; Podophyllotoxin; Teniposide; Time Factors | 1979 |
VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474).
Topics: Adult; Aged; Blood Cell Count; Clinical Trials as Topic; Drug Evaluation; Female; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Podophyllotoxin; Teniposide | 1979 |
Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow; Child; Clinical Trials as Topic; Drug Evaluation; Humans; Leukemia; Leukemia, Lymphoid; Neoplasms; Neuroblastoma; Podophyllotoxin; Remission, Spontaneous; Teniposide | 1979 |
Pediatric cancer chemotherapy: an updated review. I. Cis-Diammine--dichloroplatinum II (cisplatin), VM-26 (teniposide), VP-16 (etoposide), mitomycin C.
Topics: Child; Cisplatin; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Humans; Leukemia; Mitomycins; Neoplasms; Podophyllotoxin; Teniposide | 1979 |
Use of VM-26 as a single agent in the treatment of renal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Bone Marrow; Clinical Trials as Topic; Female; Humans; Hypotension; Kidney Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide | 1979 |
[Non resectable colonic cancer. Results from a test of chemotherapy with simultaneous prescription of VM26, methyl-CCNU and 5 fluoro-uracile (author's transl)].
Topics: Adult; Aged; BCG Vaccine; Colonic Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Humans; Immunotherapy; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1978 |
[Surgically treated supratentorial gliomas in the adult. Favourable action of a podophyllin derivative (VM 26) administered alone (author's transl)].
Topics: Brain Neoplasms; Drug Tolerance; Glioma; Humans; Podophyllotoxin; Teniposide | 1978 |
[Letter: Chemotherapy of operated malignant brain gliomas using a combination of VM 26 and CCNU].
Topics: Brain Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Glioma; Humans; Lomustine; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1976 |
[Trial treatment of glioblastomas in adults and cerebral metastais by adriamycin, VM 26 and CCNU combination. Result of a type II trial].
Topics: Adult; Aged; Brain Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Remission, Spontaneous; Teniposide | 1976 |
Preliminary evaluation of VM-26: a new epipodophyllotoxin derivative, in the treatment of urogenital tumours.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Papillary; Chemotherapy, Cancer, Regional Perfusion; Clinical Trials as Topic; Drug Evaluation; Humans; Infusions, Parenteral; Leiomyosarcoma; Male; Mitosis; Neoplasm Metastasis; Podophyllotoxin; Prostatic Neoplasms; Teniposide; Teratoma; Testicular Neoplasms; Therapeutic Irrigation; Urinary Bladder Neoplasms | 1975 |
EORTC randomized trial for the adjuvant therapy of T1 bladder carcinoma.
Topics: Carcinoma, Papillary; Clinical Trials as Topic; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Podophyllotoxin; Postoperative Care; Remission, Spontaneous; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1976 |
Phase I-II trial of VM-26 (NSC-122819) in the treatment of children with late-stage leukemia.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Drug Evaluation; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocyte Count; Podophyllotoxin; Teniposide | 1976 |
Results obtained with combination therapy of VM-26, natulan and prednisolone in generalized Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Middle Aged; Podophyllotoxin; Prednisolone; Procarbazine; Radiography; Teniposide; Time Factors | 1975 |
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Risk Factors; Teniposide | 1991 |
Teniposide and cisplatin given by intraperitoneal administration: preclinical and phase I/pharmacokinetic studies.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Drug Synergism; Etoposide; Female; Humans; Injections, Intraperitoneal; Leukemia P388; Leukopenia; Male; Mice; Middle Aged; Peritoneal Neoplasms; Podophyllotoxin; Remission Induction; Teniposide | 1991 |
VM-26 in colorectal carcinoma: a Southwest Oncology Group study.
Topics: Colorectal Neoplasms; Humans; Leukopenia; Multicenter Studies as Topic; Podophyllotoxin; Teniposide | 1990 |
Pharmacokinetics of continuous infusion of methotrexate and teniposide in pediatric cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Drug Administration Schedule; Humans; Infusions, Intravenous; Leucovorin; Metabolic Clearance Rate; Methotrexate; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1990 |
Combination chemotherapy of hepatocellular cancer. Comparison of adriamycin + VM 26 + 5-fluorouracil with mAMSA + VM 26 + 5-fluorouracil.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Clinical Trials as Topic; Doxorubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Podophyllotoxin; Random Allocation; Teniposide; Time Factors | 1987 |
The epipodophyllotoxin teniposide in therapy for childhood acute lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Cytarabine; Dose-Response Relationship, Drug; Humans; Leukemia, Lymphoid; Podophyllotoxin; Teniposide | 1988 |
Teniposide in epithelial ovarian carcinoma: a phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Middle Aged; Ovarian Neoplasms; Podophyllotoxin; Prognosis; Teniposide | 1986 |
Phase II study of teniposide (VM-26) in multiple myeloma.
Topics: Adult; Aged; Blood Cell Count; Blood Proteins; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Immunoglobulins; Infusions, Parenteral; Leukopenia; Male; Middle Aged; Multiple Myeloma; Podophyllotoxin; Teniposide | 1985 |
Adjuvant chemotherapy with VM 26 and CCNU after operation and radiotherapy of high-grade supratentorial astrocytomas.
Topics: Adult; Aged; Brain Neoplasms; Drug Therapy, Combination; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1980 |
[New antineoplastic drugs of the podophyllotoxin derivative group].
Topics: Adult; Child; Clinical Trials as Topic; Etoposide; Female; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1983 |
VM-26 and dimethyl triazeno imidazole carboxamide in Ewing's sarcoma.
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Podophyllotoxin; Random Allocation; Sarcoma, Ewing; Teniposide; Vincristine | 1983 |
Teniposide: a review of 12 years of experience.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Cycle; Cell Line; Child; Clinical Trials as Topic; Colonic Neoplasms; DNA, Neoplasm; Drug Evaluation, Preclinical; Drug Resistance; Humans; Leukemia; Lymphoma; Mice; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Podophyllotoxin; Teniposide | 1984 |
Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM26) and TUR alone.
Topics: Carcinoma, Transitional Cell; Clinical Trials as Topic; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Podophyllotoxin; Random Allocation; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1982 |
Comparative trial of two teniposide-based combination chemotherapy regimens for the treatment of advanced malignant lymphomas.
Topics: Adult; Altretamine; Cisplatin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hematopoietic System; Humans; Lymphoma; Male; Middle Aged; Podophyllotoxin; Prednisone; Prospective Studies; Random Allocation; Teniposide | 1982 |
[Results of a clinical study of an epipodophyllotoxin preparation (VM 26) in children with hemoblastoses].
Topics: Child; Clinical Trials as Topic; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Podophyllotoxin; Prednisolone; Teniposide; Time Factors | 1981 |
[Use of preparation VM 26 (epipodophyllotoxin) for treating lymphomas in children and adults].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Hodgkin Disease; Humans; Infant; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Podophyllotoxin; Teniposide; Time Factors | 1981 |
Combination chemotherapy for patients with relapsed malignant lymphoma using methyl-GAG and teniposide (VM-26).
Topics: Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Guanidines; Humans; Lymphoma; Mitoguazone; Podophyllotoxin; Teniposide | 1982 |
Comparison of the use of teniposide and vincristine in combination chemotherapy for non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hematologic Diseases; Humans; Kidney Diseases; Lymphoma; Podophyllotoxin; Prednisolone; Teniposide; Vincristine | 1982 |
201 other study(ies) available for arginine and podophyllotoxin
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparative study of early effects of epipodophyllotoxin derivatives and other cytostatic agents on mastocytoma cultures.
Topics: Antineoplastic Agents; Bleomycin; Cell Division; Cell Line; Colchicine; Cytarabine; DNA, Neoplasm; Etoposide; Mast-Cell Sarcoma; Mechlorethamine; Mercaptopurine; Methotrexate; Mitosis; Neoplasm Proteins; Neoplasms, Experimental; Podophyllotoxin; Razoxane; RNA, Neoplasm; Teniposide; Vincristine; X-Rays | 1977 |
Single-drug chemotherapy of bladder cancer with adriamycin, VM-26 or bleomycin. A phase II multicentric, co-operative study.
Topics: Bleomycin; Doxorubicin; Humans; Neoplasm Metastasis; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1976 |
[Role of VM26 on glioma cells in vitro--analysis of G0 cells and recruitment (author's transl)].
Topics: Brain Neoplasms; Cells, Cultured; Glioma; Kinetics; Mitosis; Podophyllotoxin; Teniposide | 1978 |
Effects of the epipodophyllotoxin derivative VM 26 in mitosis and in interphase.
Topics: Animals; Cell Cycle; Cell Line; Interphase; Mast-Cell Sarcoma; Mitosis; Podophyllotoxin; Sarcoma, Experimental; Teniposide | 1978 |
Delayed pyridine nucleotide reoxidation induced by the anticancer agent VM-26 as measured in vivo and in situ by NADH microfluorimetry.
Topics: Animals; Brain; Female; Fluorometry; Hypoxia; Mitochondria; NAD; Oxidation-Reduction; Oxygen Consumption; Podophyllotoxin; Rats; Rhabdomyosarcoma; Sarcoma, Experimental; Teniposide | 1975 |
[Treatment of inoperable glioblastomas using a combination of adriamycin, VM 26 and CCNU].
Topics: Adult; Aged; Brain Neoplasms; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Glioblastoma; Humans; Lomustine; Methods; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1977 |
VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Teniposide; Thrombocytopenia | 1978 |
[Value of chemotherapy associated with conventional treatment of malignant gliomas of the brain. Study of 95 cases with histological verification and follow-up of 1 to 6 years 9 months].
Topics: Administration, Oral; Adult; Brain Neoplasms; Carmustine; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Glioblastoma; Glioma; Humans; Injections, Intravenous; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Retrospective Studies; Teniposide | 1979 |
Recruitment-chemoradiotherapy with VM 26 (epipodophyllotoxin) for induction treatment of malignant brain tumours.
Topics: Adenocarcinoma; Animals; Brain Neoplasms; Cell Line; Fibrosarcoma; Glioma; Humans; Mitosis; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Podophyllotoxin; Radiotherapy Dosage; Rats; Teniposide; Vincristine | 1979 |
[Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Prednisone; Teniposide | 1977 |
VM-26 as a second drug in the treatment of brain gliomas.
Topics: Antineoplastic Agents; Brain Neoplasms; Drug Therapy, Combination; Female; Glioma; Humans; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1979 |
Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Drug Therapy, Combination; Female; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1979 |
Malignant gliomas treated after surgery by combination chemotherapy and delayed irradiation. Part I: Analysis of results.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Cobalt Radioisotopes; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Podophyllotoxin; Radiotherapy Dosage; Teniposide | 1979 |
Malignant gliomas treated after surgery by combination chemotherapy and delayed radiation therapy. Part II. Tolerance to irradiation after chemotherapy.
Topics: Brain; Brain Neoplasms; Drug Therapy, Combination; Glioma; Humans; Lomustine; Neoplasm Recurrence, Local; Nitrosourea Compounds; Podophyllotoxin; Radiation Tolerance; Radiotherapy; Radiotherapy Dosage; Teniposide | 1979 |
A quantitative microdensitometric and autoradiographic study of the effect of 4'-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside (VM-26) on the cell cycle of cultured fibroblasts.
Topics: Animals; Cell Cycle; Cell Nucleus; Cells, Cultured; Chick Embryo; DNA; Fibroblasts; Mitochondria; Mitosis; Podophyllotoxin; Proteins; RNA; Teniposide | 1979 |
[Effectiveness of VM 26, mitomycine C and methotrexate in advanced breast cancer refractory to a four drug combination (author's transl)].
Topics: Adult; Aged; Breast Neoplasms; Drug Resistance; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle Aged; Mitomycins; Neoplasm Metastasis; Podophyllotoxin; Teniposide | 1979 |
Uridine enhances the chemotherapeutic action of the 4'-demethylepipodophyllotoxin-thenylidene-glucoside (VM 26)-cyclophosphamide combination on i.m. implanted Ehrlich carcinoma.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Female; Mice; Neoplasm Transplantation; Podophyllotoxin; Teniposide; Transplantation, Homologous; Uridine | 1978 |
Epipodophyllotoxin VM-26 in the treatment of childhood neuroblastoma.
Topics: Blood Cells; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infusions, Parenteral; Male; Neuroblastoma; Podophyllotoxin; Teniposide | 1977 |
Iv methyl-CCNU, VM-26, and cranial irradiation in therapy for malignant brain tumors.
Topics: Brain Neoplasms; Humans; Injections, Intravenous; Leukopenia; Nitrosourea Compounds; Podophyllotoxin; Semustine; Teniposide | 1977 |
Comparison of uptake and binding of two epipodophyllotoxin glucopyranosides, 4'-demethyl epipodophyllotoxin thenylidene-beta-D-glucoside and 4'-demethyl epipodophyllotoxin ethylidene-beta-D-glucoside, in the L1210 leukemia cell.
Topics: Animals; Binding Sites; Biological Transport; Cell Nucleus; Etoposide; Kinetics; Leukemia L1210; Mice; Mice, Inbred DBA; Podophyllotoxin; Teniposide; Thermodynamics; Vinblastine | 1978 |
Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners.
Topics: Animals; Etoposide; In Vitro Techniques; Magnetic Resonance Spectroscopy; Microtubules; Podophyllotoxin; Stereoisomerism; Structure-Activity Relationship; Teniposide; Tubulin | 1978 |
Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.
Topics: Animals; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Etoposide; Hematopoietic Stem Cells; Leukemia L1210; Podophyllotoxin; Rats; Teniposide; Time Factors | 1978 |
Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation.
Topics: Adult; Aged; Brain Neoplasms; Carmustine; Drug Therapy, Combination; Female; Glioma; Humans; Male; Middle Aged; Podophyllotoxin; Postoperative Period; Teniposide | 1978 |
The role of drug disposition kinetics on cellular transport of the antineoplastic agent VM-26.
Topics: Animals; Biological Transport, Active; Chemical Phenomena; Chemistry; Diffusion; Etoposide; Kinetics; Leukemia L1210; Mice; Models, Biological; Podophyllotoxin; Protein Binding; Serum Albumin; Teniposide | 1978 |
[Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV].
Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Seeding; Podophyllotoxin; Prednisone; Remission, Spontaneous; Teniposide | 1975 |
VM26-induced changes in hepatic intermediary metabolism of mice.
Topics: Animals; Blood Glucose; Doxorubicin; Drug Synergism; Female; Glucose; Hexosephosphates; In Vitro Techniques; Isocitrates; Ketoglutaric Acids; Leukemia L1210; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mitochondria, Liver; Oxygen Consumption; Podophyllotoxin; Succinates; Teniposide | 1977 |
VM 26 (4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside) in the treatment of urinary bladder tumors.
Topics: Carcinoma, Papillary; Humans; Podophyllotoxin; Recurrence; Remission, Spontaneous; Teniposide; Time Factors; Urinary Bladder Neoplasms | 1977 |
Antimetastasis effect of two derivatives of epiposophyllotoxin in mice.
Topics: Animals; Etoposide; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Podophyllotoxin; Solvents; Teniposide; Time Factors | 1976 |
Delayed toxicity of epipodophyllotoxin derivatives (VM 26 and VP 16-213), due to a local effect.
Topics: Animals; Dose-Response Relationship, Drug; Etoposide; Female; Injections, Intraperitoneal; Injections, Intravenous; Leukemia L1210; Liver; Lung; Male; Mice; Organ Size; Podophyllotoxin; Rats; Teniposide; Time Factors | 1976 |
Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail.
Topics: Adult; Aged; Brain Neoplasms; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; Glioma; Hematologic Diseases; Humans; Intracranial Pressure; Lomustine; Male; Middle Aged; Nausea; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Teniposide; Vomiting | 1976 |
Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotixin glucopyranoside derivatives.
Topics: Body Water; Etoposide; Humans; Metabolic Clearance Rate; Models, Biological; Neoplasms; Podophyllotoxin; Teniposide | 1975 |
Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.
Topics: Animals; Cytarabine; Drug Therapy, Combination; Etoposide; Female; Leukemia L1210; Leukemia, Experimental; Mice; Podophyllotoxin; Pyrans; Teniposide | 1975 |
Combination chemotherapy based on a model of cell recruitment by partial synchronization.
Topics: Drug Therapy, Combination; Humans; Mitosis; Mitotic Index; Models, Biological; Neoplasm Metastasis; Neoplasms; Podophyllotoxin; Remission, Spontaneous; Teniposide; Time Factors; Vincristine | 1975 |
Synthesis and biological activity of galactopyranoside derivatives of 4'-demethylepipodophyllotoxin showing VP-16 (etoposide)-like activity.
Topics: Acetals; Animals; Antineoplastic Agents; CHO Cells; Cricetinae; DNA; DNA Damage; Etoposide; Galactose; Podophyllotoxin; Structure-Activity Relationship; Teniposide | 1991 |
Tests for the genotoxicity of m-AMSA, etoposide, teniposide and ellipticine in Neurospora crassa.
Topics: Alkaloids; Amsacrine; Ellipticines; Etoposide; Molecular Structure; Mutagenicity Tests; Mutagens; Neurospora crassa; Podophyllotoxin; Teniposide | 1990 |
Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication.
Topics: Adenovirus Early Proteins; Adenoviruses, Human; Camptothecin; DNA Replication; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Viral; HeLa Cells; Humans; Kinetics; Oncogene Proteins, Viral; Podophyllotoxin; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1990 |
Transcription of adenovirus and HeLa cell genes in the presence of drugs that inhibit topoisomerase I and II function.
Topics: Adenovirus Early Proteins; Adenoviruses, Human; Antigens, Viral, Tumor; Camptothecin; Exons; Genes; Genes, Viral; Heat-Shock Proteins; HeLa Cells; Humans; Kinetics; Oncogene Proteins, Viral; Podophyllotoxin; RNA, Messenger; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transcription, Genetic | 1990 |
Inhibition of topoisomerase II does not inhibit transcription of RNA polymerase I and II genes.
Topics: Animals; Chromatin; Female; Genes; Kinetics; Oocytes; Plasmids; Podophyllotoxin; Recombination, Genetic; RNA Polymerase I; RNA Polymerase II; RNA, Ribosomal; Teniposide; Thymidine Kinase; Topoisomerase II Inhibitors; Transcription, Genetic; Xenopus laevis | 1990 |
Effects of the DNA topoisomerase II inhibitor, VM26, on transcriptional initiation in vitro.
Topics: Animals; Cells, Cultured; Cloning, Molecular; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Podophyllotoxin; Prolactin; Promoter Regions, Genetic; Rats; Teniposide; Topoisomerase II Inhibitors; Transcription, Genetic | 1990 |
Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA.
Topics: Amsacrine; Animals; Antineoplastic Agents; Cell Nucleus; Crithidia; DNA; DNA Topoisomerases, Type II; Drug Resistance; Humans; Leukemia; Podophyllotoxin; Teniposide; Tumor Cells, Cultured | 1990 |
Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines.
Topics: DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Humans; KB Cells; Podophyllotoxin; Temperature; Teniposide | 1990 |
Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion.
Topics: Aged; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Podophyllotoxin; Teniposide | 1990 |
Partitioning of teniposide into membranes and the role of lipid composition.
Topics: Etoposide; Kinetics; Lipid Bilayers; Models, Biological; Phosphatidylcholines; Podophyllotoxin; Structure-Activity Relationship; Teniposide; Tritium | 1990 |
Phase II study of teniposide (VM26) in cutaneous T-cell lymphomas.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Lymphoma; Male; Middle Aged; Mycosis Fungoides; Podophyllotoxin; Prognosis; Remission Induction; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes; Teniposide | 1990 |
Phase II study of teniposide in advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1990 |
Teniposide (VM-26) in patients with non-squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Carcinoma; Drug Administration Schedule; Drug Evaluation; Female; Humans; Middle Aged; Podophyllotoxin; Prognosis; Teniposide; Uterine Cervical Neoplasms | 1990 |
Precipitation of teniposide during infusion.
Topics: Chemistry, Pharmaceutical; Drug Stability; Infusions, Intravenous; Podophyllotoxin; Teniposide | 1990 |
Teniposide in recurrent or advanced cervical carcinoma: a phase II trial in patients not previously treated with cytotoxic therapy.
Topics: Adult; Aged; Carcinoma; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Survival; Teniposide; Uterine Cervical Neoplasms | 1990 |
Effects of the lipophilic anticancer drug teniposide (VM-26) on membrane transport.
Topics: Amino Acids; Animals; Biological Transport; Carcinoma, Ehrlich Tumor; Carrier Proteins; Cell Membrane; Cell Membrane Permeability; Cytarabine; Etoposide; Humans; Membrane Lipids; Membranes, Artificial; Nucleosides; Podophyllotoxin; Teniposide; Tumor Cells, Cultured | 1990 |
Vidarabin-monophosphate, BCNU, VM26--an in vitro comparative study of active agents in the treatment of malignant human brain tumours.
Topics: Adolescent; Aged; Arabinonucleotides; Brain Neoplasms; Carmustine; Cells, Cultured; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Kinetics; Male; Middle Aged; Neoplastic Stem Cells; Podophyllotoxin; RNA, Neoplasm; Teniposide; Vidarabine Phosphate | 1987 |
VM-26 (teniposide)-induced hypersensitivity and degranulation of basophils in children.
Topics: Adolescent; Allergens; Basophils; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Histamine Release; Humans; Infant; Male; Neuroblastoma; Podophyllotoxin; Polyethylene Glycols; Risk Factors; Teniposide | 1988 |
DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells.
Topics: Amsacrine; Animals; Bisbenzimidazole; Cell Nucleus; Deoxyribonucleoproteins; Distamycins; DNA Damage; DNA, Neoplasm; Indoles; Kinetics; Leukemia L1210; Mice; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors | 1989 |
Studies of topoisomerase-specific antitumor drugs in human lymphocytes using rabbit antisera against recombinant human topoisomerase II polypeptide.
Topics: Animals; Antibodies; Base Sequence; Camptothecin; Chromosome Aberrations; Cloning, Molecular; DNA Replication; DNA Topoisomerases, Type II; Escherichia coli; Genes; Genetic Vectors; Humans; Immune Sera; Lymphocyte Activation; Lymphocytes; Molecular Sequence Data; Podophyllotoxin; Rabbits; Recombinant Proteins; Teniposide; Topoisomerase II Inhibitors | 1989 |
Reduced formation of lesions in the DNA of a multidrug-resistant L1210 subline selected for teniposide resistance.
Topics: Animals; DNA; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Leukemia L1210; Podophyllotoxin; Potassium Cyanide; Teniposide; Tumor Cells, Cultured; Verapamil | 1989 |
Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells.
Topics: Culture Media; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Resistance; Humans; Hybrid Cells; Leukemia, T-Cell; Phenotype; Podophyllotoxin; Teniposide; Tumor Cells, Cultured | 1989 |
Evidence for the reversibility of cellular DNA lesion induced by mammalian topoisomerase II poisons.
Topics: Animals; Cell Line; DNA Damage; HeLa Cells; Mice; Podophyllotoxin; Substrate Specificity; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1989 |
A study of drug-induced topoisomerase II-mediated DNA lesions on episomal chromatin.
Topics: Amsacrine; Blotting, Southern; Cell Line; Chromatin; Dexamethasone; DNA Damage; DNA Topoisomerases, Type II; Genes; Kinetics; Plasmids; Podophyllotoxin; Teniposide | 1989 |
Altered formation of DNA in human cells treated with inhibitors of DNA topoisomerase II (etoposide and teniposide).
Topics: DNA Replication; DNA, Neoplasm; Etoposide; Humans; Kinetics; Melanoma; Podophyllotoxin; Teniposide; Thymidine; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1989 |
Increased ATP requirement for activity of and complex formation by DNA topoisomerase II from human leukemic CCRF-CEM cells selected for resistance to teniposide.
Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Amsacrine; Cell Line; Cell Nucleus; DNA Topoisomerases, Type I; DNA, Neoplasm; Drug Resistance; Humans; Kinetics; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding; Teniposide; Tumor Cells, Cultured | 1989 |
Expression of protein-associated DNA damage in the alkaline elution assay in the absence of enzymatic deproteinization.
Topics: Animals; Cell Line; DNA Damage; DNA Replication; DNA Topoisomerases, Type II; DNA, Neoplasm; Endopeptidase K; Etoposide; Humans; Hydrogen-Ion Concentration; Leukemia L1210; Liver Neoplasms, Experimental; Mice; Mitoxantrone; Podophyllotoxin; Protein Binding; Rats; Serine Endopeptidases; Teniposide; Tumor Cells, Cultured | 1989 |
Anaphylactic reactions to teniposide.
Topics: Adolescent; Anaphylaxis; Child; Child, Preschool; Etoposide; Humans; Infusions, Intravenous; Podophyllotoxin; Teniposide | 1989 |
Teniposide-induced hypersensitivity reactions in children.
Topics: Anaphylaxis; Child; Humans; Podophyllotoxin; Polyethylene Glycols; Teniposide | 1989 |
[VM-26 and VP-16 salvage therapy for refractory germinal testicular cancers].
Topics: Adult; Choriocarcinoma; Dysgerminoma; Etoposide; Humans; Male; Middle Aged; Podophyllotoxin; Teniposide; Teratoma; Testicular Neoplasms | 1989 |
Automated reversed-phase chromatographic analysis of etoposide and teniposide in plasma by using on-line surfactant-mediated sample clean-up and column-switching.
Topics: Chromatography, High Pressure Liquid; Electrochemistry; Etoposide; Humans; Podophyllotoxin; Spectrometry, Fluorescence; Teniposide | 1989 |
[Phase I trial and pharmacokinetics of VM 26 combined with cisplatin administered by the intraperitoneal route without mixing time].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasms; Podophyllotoxin; Teniposide | 1989 |
Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26).
Topics: Abdominal Neoplasms; Adult; Aged; Ascites; Bone Marrow; Drug Evaluation; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Podophyllotoxin; Teniposide | 1989 |
A pharmacokinetic model for intraperitoneal administration of drugs: application to teniposide in humans.
Topics: Adolescent; Half-Life; Humans; Injections, Intraperitoneal; Models, Biological; Podophyllotoxin; Teniposide | 1989 |
Effects of the anticancer agent VM-26 on hexose uptake in Ehrlich cells.
Topics: 3-O-Methylglucose; Animals; Carcinoma, Ehrlich Tumor; Cytochalasin B; Deoxyglucose; Hexokinase; Hexoses; Kinetics; Male; Methylglucosides; Mice; Mice, Inbred Strains; Monosaccharide Transport Proteins; Phosphorylation; Podophyllotoxin; Teniposide; Tumor Cells, Cultured | 1989 |
Treatment strategies in relation to drug action.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; DNA Topoisomerases, Type II; Etoposide; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Podophyllotoxin; Teniposide | 1987 |
Involvement of intracellular ATP in cytotoxicity of topoisomerase II-targetting antitumor drugs.
Topics: Adenosine Triphosphate; Camptothecin; Cell Survival; Cell Transformation, Neoplastic; Dinitrophenols; HeLa Cells; Humans; Kinetics; Podophyllotoxin; Simian virus 40; Teniposide; Topoisomerase II Inhibitors | 1987 |
Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cells.
Topics: Amsacrine; Burkitt Lymphoma; Cell Line; Cell Survival; Chromatin; DNA Topoisomerases, Type II; Drug Resistance; Humans; Kinetics; Mechlorethamine; Novobiocin; Podophyllotoxin; Teniposide; Tumor Stem Cell Assay | 1987 |
Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Humans; Infusions, Intravenous; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Pericardial Effusion; Pericardium; Podophyllotoxin; Teniposide | 1987 |
Topoisomerase-II-mediated lesions in nascent DNA: comparison of the effects of epipodophyllotoxin derivatives, VM-26 and VP-16, and 9-anilinoacridine derivatives, m-AMSA and o-AMSA.
Topics: Adenosine Triphosphate; Amsacrine; Animals; Cross-Linking Reagents; DNA; DNA Damage; DNA Replication; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Leukemia L1210; Mice; Novobiocin; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors | 1988 |
Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung.
Topics: Aged; Brain Neoplasms; Carcinoma, Small Cell; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1988 |
Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.
Topics: Aged; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Prognosis; Teniposide | 1988 |
DNA binding by epipodophyllotoxins and N-acyl anthracyclines: implications for mechanism of topoisomerase II inhibition.
Topics: Antibiotics, Antineoplastic; DNA; DNA, Mitochondrial; Etoposide; In Vitro Techniques; Plasmids; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors | 1988 |
Effects of VM26, a specific inhibitor of type II DNA topoisomerase, on SV40 chromatin replication in vitro.
Topics: Animals; Aphidicolin; Cell Line; Chromatin; Diterpenes; DNA Replication; DNA Topoisomerases, Type I; Kinetics; Podophyllotoxin; Simian virus 40; Teniposide; Topoisomerase II Inhibitors; Virus Replication | 1988 |
Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC).
Topics: Aged; Aged, 80 and over; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide | 1988 |
Podophyllotoxins for brain metastases of small cell lung cancer.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide | 1988 |
Induction of sister chromatid exchanges by inhibitors of topoisomerases.
Topics: Amsacrine; Animals; Camptothecin; Cells, Cultured; Cricetinae; DNA Topoisomerases, Type I; Enzyme Inhibitors; Fibroblasts; Podophyllotoxin; Sister Chromatid Exchange; Teniposide | 1986 |
Successful induction with chemotherapy including teniposide in familial erythrophagocytic lymphohistiocytosis.
Topics: Child, Preschool; Drug Evaluation; Erythrocytes; Humans; Infant; Lymphatic Diseases; Lymphocytes; Male; Phagocytosis; Podophyllotoxin; Remission Induction; Teniposide | 1986 |
Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Chloroquine; Chromosome Banding; Chromosomes, Human, Pair 13; Colchicine; Dactinomycin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Leukemia; Membrane Glycoproteins; Molecular Weight; Podophyllotoxin; Teniposide; Tumor Cells, Cultured; Verapamil; Vinblastine; Vinca Alkaloids | 1987 |
Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells.
Topics: Animals; Cells, Cultured; Chemical Precipitation; DNA Topoisomerases, Type II; DNA, Viral; Etoposide; Haplorhini; Novobiocin; Podophyllotoxin; Simian virus 40; Teniposide | 1985 |
Peroxidative free radical formation and O-demethylation of etoposide(VP-16) and teniposide(VM-26).
Topics: Chromatography, High Pressure Liquid; Electron Spin Resonance Spectroscopy; Etoposide; Free Radicals; Horseradish Peroxidase; Mass Spectrometry; Oxidoreductases, O-Demethylating; Peroxides; Podophyllotoxin; Prostaglandin-Endoperoxide Synthases; Quinones; Teniposide | 1986 |
Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
Topics: Aged; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Teniposide | 1986 |
DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
Topics: Adenocarcinoma; Adenosine Triphosphate; Carcinoma, Small Cell; Cell Division; Cell Nucleus; Cells, Cultured; DNA; DNA, Single-Stranded; Drug Resistance; Etoposide; Humans; Intercalating Agents; Lung Neoplasms; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors | 1986 |
A case of small cell lung cancer successfully treated with VM26.
Topics: Aged; Carcinoma, Small Cell; Drug Evaluation; Humans; Lung Neoplasms; Male; Podophyllotoxin; Teniposide | 1986 |
Membrane ordering effects of the anticancer agent VM-26.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Carcinoma, Ehrlich Tumor; Cell Line; Cell Membrane; Cholesterol; Cyclic N-Oxides; Dimyristoylphosphatidylcholine; Electron Spin Resonance Spectroscopy; Etoposide; Humans; Leukemia; Lipid Bilayers; Liposomes; Male; Membrane Lipids; Mice; Podophyllotoxin; Spin Labels; Teniposide | 1986 |
Teniposide in the treatment of non-small cell lung carcinoma.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide | 1987 |
Effects of VM26 (teniposide), a specific inhibitor of type II DNA topoisomerase, on SV40 DNA replication in vivo.
Topics: Animals; Cell Line; DNA Replication; DNA, Viral; Podophyllotoxin; Simian virus 40; Teniposide; Topoisomerase II Inhibitors; Virus Replication | 1987 |
Protein-linked DNA strand breaks produced by etoposide and teniposide in mouse L1210 and human VA-13 and HT-29 cell lines: relationship to cytotoxicity.
Topics: Animals; Cell Line; Cell Survival; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Humans; Kinetics; Leukemia L1210; Podophyllotoxin; Teniposide | 1987 |
Uptake and binding of teniposide (VM26) in Krebs II ascites cells.
Topics: Animals; Biological Transport; Carcinoma, Krebs 2; Chromatography, High Pressure Liquid; Edetic Acid; Female; Iodoacetamide; Kinetics; Mice; Ouabain; Podophyllotoxin; Sodium; Teniposide | 1987 |
Structure-bioactivation relationship of a series of podophyllotoxin derivatives.
Topics: Animals; Cell Survival; Cytochrome P-450 Enzyme System; Etoposide; Male; Methylcholanthrene; Microsomes, Liver; Phenobarbital; Podophyllotoxin; Rats; Rats, Inbred Strains; Spectrophotometry; Structure-Activity Relationship; Teniposide | 1988 |
[Cytosine arabinoside and VM-26 in induction treatment, failures and recurrences of childhood acute lymphoblastic leukemias].
Topics: Child; Child, Preschool; Cytarabine; Drug Combinations; Female; Humans; Male; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Risk Factors; Teniposide | 1988 |
Etoposide (VP16) and teniposide (VM26): novel anticancer drugs, strongly mutagenic in mammalian but not prokaryotic test systems.
Topics: Animals; Cell Line; Escherichia coli; Etoposide; Hypoxanthine Phosphoribosyltransferase; L Cells; Mice; Mutagenicity Tests; Mutagens; Mutation; Podophyllotoxin; Salmonella typhimurium; Teniposide | 1987 |
Phase II evaluation of teniposide (VM-26) in metastatic breast carcinoma. A Southeastern Cancer Study Group trial.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Drug Resistance; Female; Humans; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Teniposide | 1988 |
[Use of VM-26 as a single agent in the treatment of transitional cell carcinoma of the urinary tract].
Topics: Adult; Aged; Carcinoma, Transitional Cell; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Podophyllotoxin; Teniposide; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1988 |
Synthesis and structure-activity relationships among glycosidic derivatives of 4'-demethylepipodophyllotoxin and epipodophyllotoxin, showing VM26- and VP16-213-like activities.
Topics: Antineoplastic Agents; Cell Line; Drug Resistance; Etoposide; Podophyllotoxin; Structure-Activity Relationship; Teniposide | 1987 |
Synthesis and biological activities of the C-4 esters of 4'-demethylepipodophyllotoxin.
Topics: Antineoplastic Agents; Cell Line; Drug Resistance; Esters; Etoposide; Mitotic Index; Podophyllotoxin; Structure-Activity Relationship; Teniposide | 1987 |
Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26).
Topics: Cell Line; Drug Resistance; Flow Cytometry; Humans; Leukemia, Lymphoid; Podophyllotoxin; Teniposide | 1987 |
Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia.
Topics: Adult; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Lymphoid; Male; Middle Aged; Podophyllotoxin; Prednisone; Prognosis; Teniposide; Vincristine | 1987 |
Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Leukemia, Lymphoid; Middle Aged; Podophyllotoxin; Prognosis; Teniposide | 1987 |
Severe hypertensive reactions to teniposide (VM-26) in infants with congenital leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Hypertension; Infant; Infant, Newborn; Leukemia, Lymphoid; Leukemia, Myeloid; Podophyllotoxin; Teniposide | 1987 |
Hypersensitivity reactions to teniposide (VM-26): an analysis.
Topics: Adolescent; Adult; Aged; Bibliographies as Topic; Blood Pressure; Brain Neoplasms; Child; Child, Preschool; Data Collection; Drug Evaluation; Drug Hypersensitivity; Edema; Humans; Hypersensitivity, Immediate; Infant; Leukemia; Male; Middle Aged; Neuroblastoma; Podophyllotoxin; Surveys and Questionnaires; Teniposide; Urticaria | 1986 |
Total-body irradiation and high-dose teniposide: a pilot study in bone marrow transplantation for patients with relapsed acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Leukemia, Lymphoid; Male; Pilot Projects; Podophyllotoxin; Teniposide; Whole-Body Irradiation | 1987 |
[Familial erythrocyto-phagocytic lymphohistiocytosis--successful treatment of 4 children].
Topics: Child, Preschool; Erythrocytes; Female; Histiocytes; Humans; Infant; Lymphatic Diseases; Lymphocytes; Male; Phagocytosis; Podophyllotoxin; Syndrome; Teniposide | 1987 |
Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line; Cyanides; Drug Resistance; Leukemia L1210; Lipid Metabolism; Mice; Neoplasm Proteins; Phenotype; Podophyllotoxin; Teniposide; Verapamil | 1987 |
Pharmacokinetics of high-dose teniposide.
Topics: Adult; Chromatography, High Pressure Liquid; Female; Humans; Kinetics; Male; Mathematics; Middle Aged; Podophyllotoxin; Teniposide | 1987 |
Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial.
Topics: Child; Drug Administration Schedule; Drug Evaluation; Humans; Infusions, Parenteral; Kinetics; Leukemia; Lymphoma; Neuroblastoma; Podophyllotoxin; Teniposide | 1987 |
The role of histamine in doxorubicin and teniposide-induced cardiotoxicity in dog and mouse.
Topics: Animals; Chlorpheniramine; Dogs; Doxorubicin; Female; Heart; Histamine; Male; Mice; Myocardium; Podophyllotoxin; Teniposide | 1987 |
Teniposide in squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Middle Aged; Podophyllotoxin; Teniposide; Uterine Cervical Neoplasms | 1987 |
Hypersensitivity reactions to teniposide in children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Hypersensitivity; Female; Humans; Infant; Male; Podophyllotoxin; Teniposide | 1987 |
Teniposide is not effective in chronic lymphocytic leukemia.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Infusions, Parenteral; Leukemia, Lymphoid; Male; Middle Aged; Podophyllotoxin; Teniposide | 1986 |
Non-Hodgkin's lymphomas in the elderly: prospective studies with specifically devised chemotherapy regimens in 66 patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Podophyllotoxin; Prednimustine; Prospective Studies; Teniposide | 1987 |
Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands Joint Study Group for Ovarian Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Hematologic Diseases; Humans; Nausea; Ovarian Neoplasms; Podophyllotoxin; Prognosis; Teniposide | 1987 |
Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.
Topics: Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Female; Humans; Kidney Neoplasms; Male; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1987 |
Comparison between VP 16 and VM 26 in Lewis lung carcinoma of the mouse.
Topics: Animals; Body Weight; Cell Count; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Etoposide; Kinetics; Leukocyte Count; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Podophyllotoxin; Teniposide | 1986 |
Quantification of teniposide in human serum by high-performance liquid chromatography with electrochemical detection.
Topics: Carcinoma; Chromatography, High Pressure Liquid; Electrochemistry; Etoposide; Female; Humans; Indicators and Reagents; Ovarian Neoplasms; Podophyllotoxin; Teniposide; Time Factors | 1986 |
High-dose teniposide for refractory malignancies: a phase I study.
Topics: Adult; Aged; Alopecia; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Middle Aged; Nausea; Neoplasms; Podophyllotoxin; Skin Diseases; Teniposide | 1986 |
Teniposide-induced changes in the physical properties of phosphatidylcholine liposomes. A calorimetric study.
Topics: Antineoplastic Agents; Calorimetry; Liposomes; Mathematics; Phosphatidylcholines; Podophyllotoxin; Teniposide; Thermodynamics | 1986 |
[Mutagenicity tests of etoposide and teniposide].
Topics: Animals; Etoposide; Male; Mice; Mutagenicity Tests; Podophyllotoxin; Teniposide | 1986 |
Pharmacokinetics and efficacy of i.v. and i.p. VM26 chemotherapy in mice bearing Krebs II ascitic tumors.
Topics: Animals; Carcinoma, Krebs 2; Dose-Response Relationship, Drug; Female; Half-Life; Injections, Intraperitoneal; Injections, Intravenous; Kinetics; Mice; Podophyllotoxin; Teniposide | 1986 |
The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung.
Topics: Animals; Carcinoma, Squamous Cell; Cell Cycle; Cell Line; Cell Survival; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Etoposide; Lung Neoplasms; Podophyllotoxin; Teniposide | 1987 |
Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells.
Topics: Animals; Carcinogens; Chromosome Aberrations; Chromosome Disorders; Leukemia L5178; Leukemia, Experimental; Mice; Mutagenicity Tests; Mutagens; Mutation; Podophyllotoxin; Teniposide; Thymidine Kinase | 1987 |
Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide.
Topics: Adenocarcinoma; Aminoacridines; Amsacrine; Cells, Cultured; DNA; DNA Repair; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin; Teniposide | 1985 |
A novel treatment of childhood lymphoblastic non-Hodgkin's lymphoma: early and intermittent use of teniposide plus cytarabine.
Topics: Adolescent; Child; Child, Preschool; Cytarabine; Drug Therapy, Combination; Female; Humans; Infant; Injections, Spinal; Lymphoma; Male; Methotrexate; Podophyllotoxin; Prognosis; Teniposide; Thymus Gland | 1985 |
Allergic reactions to teniposide in patients with neuroblastoma and lymphoid malignancies.
Topics: Child; Child, Preschool; Diphenhydramine; Drug Hypersensitivity; Humans; Leukemia, Lymphoid; Lymphoma; Neuroblastoma; Podophyllotoxin; Teniposide | 1985 |
Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
Topics: Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Podophyllotoxin; Rectal Neoplasms; Teniposide | 1986 |
Pharmacokinetics of teniposide in patients with ovarian cancer.
Topics: Adult; Ascites; Female; Humans; Infusions, Parenteral; Kinetics; Middle Aged; Ovarian Neoplasms; Podophyllotoxin; Teniposide; Time Factors | 1985 |
Inhibition of 1-beta-D-arabinofuranosylcytosine transport and net accumulation by teniposide and etoposide in Ehrlich ascites cells and human leukemic blasts.
Topics: Animals; Binding Sites; Biological Transport; Carcinoma, Ehrlich Tumor; Cells, Cultured; Cytarabine; Etoposide; Humans; Leukemia; Male; Mice; Mice, Inbred Strains; Podophyllotoxin; Teniposide; Thioinosine; Tritium | 1985 |
Pharmacokinetics of teniposide (VM 26) after IV administration in serum and malignant ascites of patients with ovarian carcinoma.
Topics: Aged; Ascitic Fluid; Carcinoma; Chromatography, High Pressure Liquid; Electrochemistry; Female; Humans; Kinetics; Mathematics; Metabolic Clearance Rate; Ovarian Neoplasms; Podophyllotoxin; Proteins; Teniposide | 1985 |
Sequential cis-platinum and VM26 in neuroblastoma: laboratory and clinical (OPEC regimen) studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Drug Synergism; Humans; Infant; Neuroblastoma; Podophyllotoxin; Prognosis; Teniposide; Vincristine | 1985 |
Serum protein reduction of the enhancement of methotrexate accumulation by vincristine and 4'-demethylepipodophyllotoxin in the Ehrlich ascites tumor cell in vitro.
Topics: Animals; Biological Transport; Blood Proteins; Carcinoma, Ehrlich Tumor; Cells, Cultured; Male; Methotrexate; Mice; Podophyllotoxin; Teniposide; Vincristine | 1985 |
Radioimmunoassay for etoposide and teniposide.
Topics: Animals; Antibody Affinity; Cross Reactions; Dogs; Etoposide; Humans; Liver; Metabolic Clearance Rate; Mice; Podophyllotoxin; Rabbits; Radioimmunoassay; Teniposide | 1985 |
[VM-26 salvage therapy for refractory or recurrent germinal testicular cancers].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dysgerminoma; Humans; Male; Neoplasm Recurrence, Local; Podophyllotoxin; Teniposide; Teratoma; Testicular Neoplasms | 1985 |
Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.
Topics: Animals; Cattle; DNA, Neoplasm; Etoposide; HeLa Cells; Humans; Kinetics; Phosphorus Radioisotopes; Podophyllotoxin; Teniposide; Thymus Gland; Topoisomerase II Inhibitors | 1984 |
Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.
Topics: Animals; Cattle; Cell Nucleus; Cell Survival; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Leukemia L1210; Mice; Podophyllotoxin; Structure-Activity Relationship; Teniposide; Thymus Gland | 1984 |
Phase II study of teniposide in small cell carcinoma of the lung.
Topics: Adult; Aged; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide | 1984 |
Acute intravascular haemolysis and renal failure due to teniposide related antibody.
Topics: Acute Kidney Injury; Anemia, Hemolytic; Antibodies; Humans; Male; Middle Aged; Podophyllotoxin; Teniposide | 1981 |
[Chemotherapy of papillomatoses of the larynx].
Topics: Bleomycin; Humans; Laryngeal Neoplasms; Male; Papilloma; Podophyllotoxin; Teniposide | 1980 |
Normal infant after combination chemotherapy including teniposide for Burkitt's lymphoma in pregnancy.
Topics: Adult; Antineoplastic Agents; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fetus; Humans; Methotrexate; Podophyllotoxin; Prednisolone; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Teniposide; Vincristine | 1982 |
Teniposide (VM-26)- and etoposide (VP-16-213)-induced augmentation of methotrexate transport and polyglutamylation in Ehrlich ascites tumor cells in vitro.
Topics: Animals; Biological Transport; Carcinoma, Ehrlich Tumor; Cells, Cultured; Chlorides; Etoposide; Glucose; Kinetics; Methotrexate; Mice; Peptides; Podophyllotoxin; Polyglutamic Acid; Teniposide; Vincristine; Water | 1982 |
VM-26 monochemotherapy trial in the treatment of recurrent supratentorial gliomas: preliminary report.
Topics: Anemia; Astrocytoma; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Female; Glioblastoma; Glioma; Humans; Kidney Diseases; Male; Neoplasm Recurrence, Local; Oligodendroglioma; Podophyllotoxin; Teniposide | 1981 |
Combination chemotherapy for metastatic brain tumors.
Topics: Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Nitrosourea Compounds; Podophyllotoxin; Prognosis; Teniposide; Tomography, X-Ray Computed | 1981 |
[Antimitotic chemotherapy of supratentorial cerebral glioma in adults. Apropos of 56 cases].
Topics: Adult; Aged; Brain Neoplasms; Drug Therapy, Combination; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1983 |
Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26.
Topics: Animals; DNA Topoisomerases, Type I; DNA, Neoplasm; Etoposide; Liver Neoplasms, Experimental; Podophyllotoxin; Rats; Structure-Activity Relationship; Teniposide; Topoisomerase II Inhibitors | 1984 |
A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients.
Topics: Adult; Age Factors; Aged; Asthenia; Drug Evaluation; Female; Humans; Leukopenia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1984 |
[Action of alkaloids from podophyllin on the response of pancreatic beta-cells of the rabbit to tolbutamide].
Topics: Animals; Etoposide; Insulin; Insulin Secretion; Islets of Langerhans; Podophyllotoxin; Rabbits; Teniposide; Tolbutamide | 1983 |
Pharmacokinetic study of VM26 given as a prolonged IV infusion to ovarian cancer patients.
Topics: Animals; Drug Administration Schedule; Female; Injections, Intravenous; Kinetics; Metabolic Clearance Rate; Ovarian Neoplasms; Podophyllotoxin; Teniposide | 1984 |
Phase II study of VM 26 in extensively pretreated breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Podophyllotoxin; Teniposide | 1984 |
Penetration of teniposide (VM-26) into human intracerebral tumors. Preliminary observations on the effect of tumor type, rate of drug infusion and prior treatment with amphotericin B or oral glycerol.
Topics: Amphotericin B; Astrocytoma; Brain Neoplasms; Glycerol; Humans; Kinetics; Meningioma; Podophyllotoxin; Teniposide | 1984 |
Establishment of an etoposide-resistant human epithelial tumour cell line in vitro: characterization of patterns of cross-resistance and drug sensitivities.
Topics: Carcinoma, Squamous Cell; Cell Line; Cisplatin; DNA, Neoplasm; Drug Resistance; Etoposide; Fluorouracil; Humans; Podophyllotoxin; Teniposide; Tongue Neoplasms; Vincristine; X-Rays | 1984 |
Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-beta-D-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) and their metabolites on
Topics: Cell Cycle; Cell Line; Cell Survival; Clone Cells; Dose-Response Relationship, Drug; Etoposide; Humans; Kinetics; Leukemia, Lymphoid; Podophyllotoxin; Structure-Activity Relationship; Teniposide | 1983 |
Teniposide (VM26) disposition in children with leukemia.
Topics: Child; Child, Preschool; Female; Humans; Kinetics; Leukemia, Lymphoid; Male; Metabolic Clearance Rate; Podophyllotoxin; Teniposide | 1984 |
4'-Demethylepipodophyllotoxin-beta-D-glucoside: a new podophyllotoxin derivative with VM-26-like and VP-16-213-like activities.
Topics: Animals; Cell Line; Cricetinae; Cricetulus; Drug Resistance; Etoposide; Female; Ovary; Podophyllotoxin; Structure-Activity Relationship; Teniposide | 1984 |
[VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Drug Evaluation; Female; Humans; Leukemia, Lymphoid; Male; Podophyllotoxin; Teniposide | 1984 |
[Treatment of acute refractory lymphoblastic leukemia in the adult with VM-26 and ARA-C].
Topics: Adolescent; Adult; Child; Cytarabine; Female; Humans; Leukemia, Lymphoid; Male; Middle Aged; Podophyllotoxin; Teniposide | 1984 |
Automated liquid chromatographic analysis of the anti-tumorigenic drugs etoposide (VP 16-213) and teniposide (VM 26).
Topics: Autoanalysis; Chromatography, Liquid; Etoposide; Humans; Hydrolysis; Podophyllotoxin; Teniposide | 1983 |
Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluents.
Topics: Adenocarcinoma; Animals; Cell Survival; Colonic Neoplasms; Etoposide; Humans; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Podophyllotoxin; Skin Ulcer; Solvents; Teniposide; Tumor Stem Cell Assay | 1983 |
High-performance liquid chromatographic analysis of the semisynthetic epipodophyllotoxins teniposide and etoposide using electrochemical detection.
Topics: Body Fluids; Chromatography, High Pressure Liquid; Electrochemistry; Etoposide; Humans; Kinetics; Podophyllotoxin; Teniposide | 1984 |
Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationship.
Topics: Adenocarcinoma; Cell Line; Cell Survival; DNA; DNA Repair; Etoposide; Humans; Kinetics; Lung Neoplasms; Podophyllotoxin; Structure-Activity Relationship; Teniposide | 1984 |
Selection and characterization of L1210 sublines resistant to teniposide (VM-26).
Topics: Animals; Cell Division; Chromosome Banding; Clone Cells; Drug Resistance; Karyotyping; Kinetics; Leukemia L1210; Metaphase; Mice; Mutation; Podophyllotoxin; Teniposide | 1984 |
Flux of teniposide (VM-26) across the plasma membrane of teniposide-resistant sublines of L1210 cells.
Topics: Animals; Biological Transport; Cell Membrane; Drug Resistance; Kinetics; Leukemia L1210; Mice; Mutation; Podophyllotoxin; Teniposide | 1984 |
Teniposide in refractory ovarian cancer: a phase II study.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Infusions, Parenteral; Leukopenia; Middle Aged; Nausea; Ovarian Neoplasms; Podophyllotoxin; Teniposide | 1984 |
Etoposide (VP-16-213) in malignant brain tumors: a phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Evaluation; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Teniposide; Time Factors; Tomography, X-Ray Computed | 1984 |
New anticancer drug class.
Topics: Child; Etoposide; Humans; Legislation, Drug; Neoplasms; Podophyllotoxin; Teniposide; United States | 1983 |
Genetic, biochemical, and cross-resistance studies with mutants of Chinese hamster ovary cells resistant to the anticancer drugs, VM-26 and VP16-213.
Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line; Cricetinae; Cricetulus; Daunorubicin; Drug Resistance; Etoposide; Female; Mutation; Ovary; Phenotype; Podophyllotoxin; Teniposide | 1983 |
Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing mice.
Topics: Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Half-Life; Kinetics; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Podophyllotoxin; Teniposide; Tissue Distribution | 1983 |
VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.
Topics: Adolescent; Antineoplastic Agents; Bone Marrow Diseases; Child; Child, Preschool; Cytarabine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Podophyllotoxin; Remission, Spontaneous; Teniposide | 1980 |
VM26 in malignant hematological diseases. A phase II study.
Topics: Drug Evaluation; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma; Multiple Myeloma; Podophyllotoxin; Teniposide | 1982 |
Cardiovascular toxic effects of VM26 in the treatment of acute lymphatic leukemia. Presentation of two cases.
Topics: Cardiovascular System; Child; Heart Failure; Humans; Hypertension; Leukemia, Lymphoid; Male; Podophyllotoxin; Teniposide | 1982 |
Glycosylated podophyllotoxin congeners: loss of microtubule inhibition and permission of invasion in vitro.
Topics: Animals; Cell Division; Chick Embryo; Etoposide; Fibrosarcoma; Mice; Microtubules; Myocardium; Organ Culture Techniques; Podophyllotoxin; Teniposide | 1982 |
VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Podophyllotoxin; Prednisone; Recurrence; Teniposide; Vincristine | 1982 |
Phase II evaluation of VM-26 in patients with metastatic transitional cell carcinoma of the urinary tract: an Eastern Cooperative Oncology Group study.
Topics: Aged; Carcinoma, Transitional Cell; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Teniposide; Urologic Neoplasms | 1982 |
Immune hemolytic anemia and renal failure due to teniposide.
Topics: Acute Kidney Injury; Anemia, Hemolytic, Autoimmune; Autoantibodies; Brain Neoplasms; Erythrocytes; Female; Humans; Kidney Tubular Necrosis, Acute; Male; Middle Aged; Podophyllotoxin; Teniposide | 1982 |
Etoposide (VP16-213) and teniposide (VM26) comparative in vitro activities in human tumors.
Topics: Antineoplastic Agents; Cells, Cultured; Etoposide; Humans; Neoplasms; Neoplasms, Experimental; Podophyllotoxin; Teniposide | 1982 |
Pharmacokinetics of Teniposide (VM26) and etoposide (VP16-213) in children with cancer.
Topics: Biotransformation; Child; Chromatography, High Pressure Liquid; Etoposide; Humans; Kinetics; Leukemia; Models, Biological; Neoplasms; Podophyllotoxin; Teniposide | 1982 |
Combination chemotherapy of the epipodophyllotoxin derivatives, teniposide and etoposide. A pharmacodynamic rationale?
Topics: Adult; Aged; Ascitic Fluid; Drug Interactions; Drug Therapy, Combination; Etoposide; Female; Humans; Kinetics; Male; Middle Aged; Models, Biological; Podophyllotoxin; Protein Binding; Teniposide | 1982 |
VM26 therapy in children with drug-refractory lymphocytic leukemia.
Topics: Child; Cytarabine; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Podophyllotoxin; Prednisone; Teniposide; Vincristine | 1982 |
Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity.
Topics: Bone Marrow; Child; Child, Preschool; Cisplatin; Drug Administration Schedule; Drug Evaluation; Humans; Hypocalcemia; Magnesium; Mitotic Index; Neuroblastoma; Parathyroid Hormone; Podophyllotoxin; Prospective Studies; Teniposide | 1981 |
Combined chemotherapy in the management of metastatic bladder cancer.
Topics: Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Humans; Mitomycins; Neoplasm Metastasis; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1981 |
Analysis of the anticancer drugs etoposide (VP 16-213) and teniposide (VM 26) by high-performance liquid chromatography with fluorescence detection.
Topics: Chromatography, High Pressure Liquid; Etoposide; Humans; Podophyllotoxin; Reference Values; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Teniposide; Time Factors | 1981 |
[Use of VM 26 (epipodophyllotoxin) in treating acute leukemias and lymphomas in the adult].
Topics: Acute Disease; Adult; Drug Evaluation; Hodgkin Disease; Humans; Leukemia; Lymphoma; Podophyllotoxin; Teniposide; Time Factors | 1981 |
VM 26 in advanced mycosis fungoides.
Topics: Adult; Aged; Bone Marrow Diseases; Female; Humans; Male; Mycosis Fungoides; Podophyllotoxin; Skin Neoplasms; Splenic Neoplasms; Teniposide | 1981 |
Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia.
Topics: Adolescent; Adult; Bone Marrow; Child; Child, Preschool; Cytarabine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hypotension; Leukemia, Lymphoid; Male; Podophyllotoxin; Recurrence; Remission, Spontaneous; Teniposide | 1980 |
Phase II study of VM-26 in adult malignancies.
Topics: Breast Neoplasms; Colonic Neoplasms; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Podophyllotoxin; Teniposide; Thrombocytopenia | 1980 |
Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatography.
Topics: Adult; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Etoposide; Humans; Isomerism; Kinetics; Male; Podophyllotoxin; Spectrometry, Fluorescence; Teniposide | 1980 |
Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors of children.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Lomustine; Male; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1980 |
Effect of VM-26 on the haematological responses of mice to L1210 leukaemia.
Topics: Animals; Female; Hematocrit; Leukemia L1210; Leukocyte Count; Mice; Neoplasm Transplantation; Platelet Count; Podophyllotoxin; Teniposide; Transplantation, Homologous | 1980 |
Sedimentation of DNA from L1210 cells after treatment with 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) or 1-beta-D-arabinofuranosylcytosine or both drugs.
Topics: Animals; Antibiotics, Antineoplastic; Centrifugation, Density Gradient; Cytarabine; Dose-Response Relationship, Drug; Drug Interactions; Leukemia L1210; Mice; Podophyllotoxin; Teniposide; Time Factors | 1980 |
Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Graft Rejection; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Humans; Life Tables; Lymphoma, Follicular; Melphalan; Middle Aged; Pancytopenia; Podophyllotoxin; Prednisone; Prognosis; Teniposide; Treatment Outcome; Vincristine; Whole-Body Irradiation | 1995 |
Induction of ovarian function by using short-term human menopausal gonadotrophin in patients with ovarian failure following cytotoxic chemotherapy for haematological malignancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Female; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Leukemia, Myelomonocytic, Acute; Luteinizing Hormone; Melphalan; Menotropins; Ovulation Induction; Podophyllotoxin; Prednisone; Pregnancy; Pregnancy, Multiple; Primary Ovarian Insufficiency; Remission Induction; Teniposide; Thioguanine; Vincristine | 1993 |
[In vitro comparison of podophyllotoxin analogues; etoposide, teniposide and NK 611 using human lung cancer cell lines].
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Division; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin; Teniposide; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1993 |
Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cadmium; Cadmium Chloride; Carcinoma, Small Cell; Cell Line; Chlorides; Cisplatin; Cross Reactions; DNA; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Humans; Lung Neoplasms; Metallothionein; Platinum Compounds; Podophyllotoxin; Teniposide; Tumor Cells, Cultured; Vinca Alkaloids | 1996 |
Discovery of podophyllotoxins.
Topics: Animals; Antineoplastic Agents, Phytogenic; Enzyme Inhibitors; Etoposide; History, 19th Century; History, 20th Century; Humans; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors | 1998 |
Protein phosphorylation associated with epipodophyllotoxin-induced apoptosis of lymphoid cells: role of a serine/threonine protein kinase.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Dexamethasone; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Inhibitors; Female; Mice; Mice, Inbred C3H; Phosphorylation; Podophyllotoxin; Protein Kinase C; Protein Serine-Threonine Kinases; Teniposide; Thymus Gland | 1998 |
Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Humans; Infant; Injections, Spinal; Leukemia-Lymphoma, Adult T-Cell; Leukemic Infiltration; Male; Methotrexate; Podophyllotoxin; Prognosis; Remission Induction; Risk; Teniposide; Treatment Outcome | 2000 |
A Highly Efficient Approach To Construct (epi)-Podophyllotoxin-4-O-glycosidic Linkages as well as Its Application in Concise Syntheses of Etoposide and Teniposide.
Topics: Antineoplastic Agents; Catalysis; Etoposide; Glycosides; Glycosylation; Molecular Structure; Podophyllotoxin; Teniposide | 2016 |
A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Gene Expression Regulation, Leukemic; High-Throughput Screening Assays; Humans; Leukocytes; Podophyllotoxin; Proto-Oncogene Proteins c-myb; Signal Transduction; Small Molecule Libraries; Teniposide | 2018 |